Madrigal Pharma (MDGL) Earnings
|
Expand Research on MDGL
| Next EPS Date | 8/11/26 | EPS Growth Rate | -24.2% |
|---|---|---|---|
| Average EPS % Beat Rate | -104.0% | Revenue Growth Rate | +64.8% |
| Average % Move 1-Wk after EPS | +5.6% | Normal Earnings Time | Before Open |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
8/11/26  |
Q226 | N/A | -$2.36 | N/A | N/A | $350.75M | N/A | N/A | N/A | ||
| 5/6/26 | Q126 | -$3.25 | -$4.19 | +$0.94 | $311.34M | $301.29M | N/A |  | | Details | |
| 2/19/26 | Q425 | -$2.57 | -$0.60 | -$1.97 | $321.1M | $310.82M | N/A | | | Details | |
| 11/4/25 | Q325 | -$5.08 | -$1.97 | -$3.11 | $287.27M | $244.42M | N/A | | | Details | |
| 8/5/25 | Q225 | -$1.90 | -$3.63 | +$1.73 | $212.8M | $159.45M | N/A | | | Details | |
| 5/1/25 | Q125 | -$3.32 | -$3.86 | +$0.54 | $137.25M | $112.54M | N/A | | | Details | |
| 2/26/25 | Q424 | -$2.71 | -$4.48 | +$1.77 | $103.32M | $87.7M | N/A | | | Details | |
| 10/31/24 | Q324 | -$4.92 | -$6.76 | +$1.84 | $62.2M | $34.09M | N/A | | | Details |
